Literature DB >> 15691623

Pleiotropic genetic effects contribute to the correlation between HDL cholesterol, triglycerides, and LDL particle size in hypertensive sibships.

Iftikhar J Kullo1, Mariza de Andrade, Eric Boerwinkle, Joseph P McConnell, Sharon L R Kardia, Stephen T Turner.   

Abstract

OBJECTIVE: Abnormalities of HDL cholesterol (HDL-C), triglycerides, and LDL particle size are present in familial dyslipidemic hypertension. We investigated heritability of these three lipid traits and the extent to which shared effects of genes (pleiotropy) contribute to the additive genetic variation in each trait in hypertensive sibships.
METHODS: Subjects included 788 individuals (60% women) ascertained through sibships with >/=2 members diagnosed with hypertension before age 60 years. The LDL particle size was measured by polyacrylamide gel electrophoresis. Triglycerides were log transformed to reduce skewness, and age- and sex-adjusted lipid traits were used in the analyses. Heritability and pairwise genetic correlations were computed using a variance components approach. The genetic correlation between a pair of traits was squared to yield genetic covariance, a measure of pleiotropic effects of genes influencing both traits concomitantly.
RESULTS: Heritability estimates indicated significant genetic effects on HDL-C (0.58), log triglycerides (0.47), and LDL particle size (0.71). Genetic correlation was strongest between HDL-C and log triglycerides (-0.642), followed by log triglycerides and LDL particle size (-0.493), and HDL-C and LDL particle size (0.334). HDL-C and log triglycerides showed the strongest genetic covariance (41%), followed by LDL particle size and log triglycerides (24%), and HDL-C and LDL particle size (11%).
CONCLUSIONS: Multivariate quantitative genetic analyses in hypertensive sibships reveal that pleiotropy contributes to the additive genetic variation in HDL-C, triglycerides, and LDL particle size. These findings provide the rationale for multivariate linkage analyses to identify novel genetic loci with pleiotropic effects on the traits.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15691623     DOI: 10.1016/j.amjhyper.2004.09.002

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  15 in total

1.  The genetic architecture of lipoprotein subclasses in Gullah-speaking African American families enriched for type 2 diabetes: the Sea Islands Genetic African American Registry (Project SuGAR).

Authors:  Jasmin Divers; Michèle M Sale; Lingyi Lu; Wei-Min Chen; Kerry H Lok; Ida J Spruill; Jyotika K Fernandes; Carl D Langefeld; W Timothy Garvey
Journal:  J Lipid Res       Date:  2009-09-25       Impact factor: 5.922

2.  Effects of diet on genetic regulation of lipoprotein metabolism in baboons.

Authors:  David L Rainwater; John L VandeBerg; Michael C Mahaney
Journal:  Atherosclerosis       Date:  2010-09-28       Impact factor: 5.162

Review 3.  The genetics of obesity and the metabolic syndrome.

Authors:  Keri L Monda; Kari E North; Steven C Hunt; D C Rao; Michael A Province; Aldi T Kraja
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2010-06       Impact factor: 2.895

4.  The effect of PPARgamma-agonism on LDL subclass profile in patients with type 2 diabetes and coronary artery disease.

Authors:  Riikka Lautamäki; Pirjo Nuutila; K E Juhani Airaksinen; Aila Leino; Heikki Hiekkanen; Marian Turiceanu; Murray Stewart; Juhani Knuuti; Tapani Rönnemaa
Journal:  Rev Diabet Stud       Date:  2006-05-10

5.  Ethnic differences in low-density lipoprotein particle size in hypertensive adults.

Authors:  Iftikhar J Kullo; M Fuad Jan; Kent R Bailey; Thomas H Mosley; Stephen T Turner
Journal:  J Clin Lipidol       Date:  2007-07       Impact factor: 4.766

6.  Genomic regions that influence plasma levels of inflammatory markers in hypertensive sibships.

Authors:  K Ding; D Feng; M de Andrade; T H Mosley; S T Turner; E Boerwinkle; I J Kullo
Journal:  J Hum Hypertens       Date:  2007-10-25       Impact factor: 3.012

7.  Evidence for linkage of a new region (11p14) to eczema and allergic diseases.

Authors:  Michel Guilloud-Bataille; Emmanuelle Bouzigon; Isabella Annesi-Maesano; Jean Bousquet; Denis Charpin; Frédéric Gormand; Joëlle Hochez; Jocelyne Just; Arnaud Lemainque; Nicole Le Moual; Régis Matran; Françoise Neukirch; Marie-Pierre Oryszczyn; Evelyne Paty; Isabelle Pin; Daniel Vervloet; Francine Kauffmann; Mark Lathrop; Florence Demenais; Marie-Hélène Dizier
Journal:  Hum Genet       Date:  2007-10-18       Impact factor: 4.132

8.  1000 Genomes-based imputation identifies novel and refined associations for the Wellcome Trust Case Control Consortium phase 1 Data.

Authors:  Jie Huang; David Ellinghaus; Andre Franke; Bryan Howie; Yun Li
Journal:  Eur J Hum Genet       Date:  2012-02-01       Impact factor: 4.246

9.  Evidence for a pleiotropic QTL on chromosome 5q13 influencing both time to asthma onset and asthma score in French EGEA families.

Authors:  Emmanuelle Bouzigon; Ayse Ulgen; Marie-Hélène Dizier; Valérie Siroux; Mark Lathrop; Francine Kauffmann; Isabelle Pin; Florence Demenais
Journal:  Hum Genet       Date:  2007-05-01       Impact factor: 5.881

10.  A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.

Authors:  Aldi T Kraja; Dhananjay Vaidya; James S Pankow; Mark O Goodarzi; Themistocles L Assimes; Iftikhar J Kullo; Ulla Sovio; Rasika A Mathias; Yan V Sun; Nora Franceschini; Devin Absher; Guo Li; Qunyuan Zhang; Mary F Feitosa; Nicole L Glazer; Talin Haritunians; Anna-Liisa Hartikainen; Joshua W Knowles; Kari E North; Carlos Iribarren; Brian Kral; Lisa Yanek; Paul F O'Reilly; Mark I McCarthy; Cashell Jaquish; David J Couper; Aravinda Chakravarti; Bruce M Psaty; Lewis C Becker; Michael A Province; Eric Boerwinkle; Thomas Quertermous; Leena Palotie; Marjo-Riitta Jarvelin; Diane M Becker; Sharon L R Kardia; Jerome I Rotter; Yii-Der Ida Chen; Ingrid B Borecki
Journal:  Diabetes       Date:  2011-03-08       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.